Neurocare Group AG

https://www.neurocaregroup.com

neurocare’s Digital Therapy Platform (DTP) is empowering clinicians to offer their patients best and most sustainable clinical outcomes through personalized therapy. These therapy plans integrate innovative methods and tools, such as psychotherapy, neuromodulation and sleep hygiene, as well as medication. Following a detailed assessment of the patient's condition, neurocare supports clinicians in developing personalized therapy plans that improve their self-regulation, resilience and social skills, while being cost effective for the healthcare system. The key technology elements of neurocare’s DTP are inhouse developed leading TMS and EEG devices, a cloud based software platform as well as an online academy for training in applying all tools or understanding the underlying neuroscience and clinical approaches. neurocare’s DTP is currently used in the company’s own clinics across the US, the Netherlands and Australia, as well as in a growing number of third-party clinics. *

	Start	2024-05-07 existent
	Industry	venture capital
	Industry 2	MedTech (medical technology)
	Person	Mechtersheimer, Thomas (Tom) (Neurocare Group 202405 CEO)

	Region	Ilmenau
	Country	Germany
	Street	3 Albert-Einstein-Str.
	City	98693 Ilmenau
	Tel	+49-89-3564767-0
		Address record changed: 2024-05-14

Basic data	Employees	n. a.

		* Document for »About Section«: Neurocare Group AG. (7/22/24). "Press Release: Neurocare Group Announces Acquisition of Smart TMS Clinics in the UK". Munich & London.

		Record changed: 2024-07-22